Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide
Open Access
- 1 January 2010
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (1) , 74-80
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Ceramide is a cardiotoxin in lipotoxic cardiomyopathyJournal of Lipid Research, 2008
- Adaptation and Maladaptation of the Heart in ObesityHypertension, 2008
- Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular MortalityPLOS ONE, 2008
- Modulation of total ceramide and constituent ceramide species in the acutely and chronically hypoxic mouse heart at different agesProstaglandins & Other Lipid Mediators, 2008
- Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in miceJournal of Clinical Investigation, 2007
- Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly–adenosine diphosphate–ribose polymeraseThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Sphingolipids and cell deathApoptosis, 2007
- Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular systemCardiovascular Research, 2007
- Cardiac Myocyte Apoptosis Is Associated With Increased DNA Damage and Decreased Survival in Murine Models of ObesityCirculation Research, 2006
- Adaptation and Maladaptation of the Heart in Diabetes: Part IICirculation, 2002